Safety of Long-Acting β-Agonists

  1. Stuart W. Stoloff, MD
  1. From University of Nevada School of Medicine, Reno, Nevada.

    TO THE EDITOR:

    The citations listed by Salpeter and colleagues (1) to support their recommendations for the use of anticholinergic agents in both acute asthma exacerbations and chronic asthma are, in fact, quoted inaccurately. Rodrigo and Castro-Rodriguez's 2005 meta-analysis clearly states that “inhaled anticholinergic agents with β2-agonists …

    [Full Text of this Article]
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med November 7, 2006 vol. 145 no. 9 707
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues